Australia
· Delayed Price · Currency is AUD AVITA Medical Statistics
Total Valuation
AVITA Medical has a market cap or net worth of AUD 367.93 million. The enterprise value is 369.89 million.
| Market Cap | 367.93M |
| Enterprise Value | 369.89M |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.92% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 25.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 21.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.47 |
| EV / Sales | 3.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.30 |
Financial Position
The company has a current ratio of 3.73, with a Debt / Equity ratio of 3.73.
| Current Ratio | 3.73 |
| Quick Ratio | 3.21 |
| Debt / Equity | 3.73 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.77 |
| Interest Coverage | -11.34 |
Financial Efficiency
Return on equity (ROE) is -152.44% and return on invested capital (ROIC) is -59.50%.
| Return on Equity (ROE) | -152.44% |
| Return on Assets (ROA) | -45.37% |
| Return on Capital (ROIC) | -59.50% |
| Revenue Per Employee | 418,337 |
| Profits Per Employee | -399,392 |
| Employee Count | 207 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.80% in the last 52 weeks. The beta is 1.54, so AVITA Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -33.80% |
| 50-Day Moving Average | 3.81 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 25.85 |
| Average Volume (20 Days) | 581,293 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.69 |
Income Statement
In the last 12 months, AVITA Medical had revenue of AUD 86.60 million and -82.67 million in losses. Loss per share was -3.21.
| Revenue | 86.60M |
| Gross Profit | 74.18M |
| Operating Income | -84.84M |
| Pretax Income | -82.61M |
| Net Income | -82.67M |
| EBITDA | -83.54M |
| EBIT | -84.84M |
| Loss Per Share | -3.21 |
Balance Sheet
The company has 64.05 million in cash and 65.81 million in debt, giving a net cash position of -1.76 million.
| Cash & Cash Equivalents | 64.05M |
| Total Debt | 65.81M |
| Net Cash | -1.76M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 17.64M |
| Book Value Per Share | 0.67 |
| Working Capital | 67.48M |
Cash Flow
In the last 12 months, operating cash flow was -74.60 million and capital expenditures -11.33 million, giving a free cash flow of -85.93 million.
| Operating Cash Flow | -74.60M |
| Capital Expenditures | -11.33M |
| Free Cash Flow | -85.93M |
| FCF Per Share | n/a |
Margins
Gross margin is 85.66%, with operating and profit margins of -97.97% and -95.47%.
| Gross Margin | 85.66% |
| Operating Margin | -97.97% |
| Pretax Margin | -95.39% |
| Profit Margin | -95.47% |
| EBITDA Margin | -96.47% |
| EBIT Margin | -97.97% |
| FCF Margin | n/a |
Dividends & Yields
AVITA Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.92% |
| Shareholder Yield | -1.92% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on June 24, 2020. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 24, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
AVITA Medical has an Altman Z-Score of -4.37. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.37 |
| Piotroski F-Score | n/a |